MM-II, a promising new treatment for knee osteoarthritis, is set to enter Phase 3 trials, with plans for regulatory approval in both the U.S. and Europe
Dr. Jency discusses oral medicine, highlighting its clinical and research roles, expertise in diagnosing complex conditions, and its impact on overall health.